memberManitoba Companies Receive Funding for COVID-19 Innovation Proof-of-Concept Grants
Research Manitoba is pleased to announce a $250,000 investment to support two COVID-19 Innovation Proof-of-Concept (IPoC) Grants to local companies
Members
BioScision Pharma Inc.
BioScision Pharma Inc. is a biopharmaceutical development and manufacturing organization focused on producing cannabinoids, terpenes and flavonoids for the Canadian and international medical and adult-use markets using proprietary expression and purification processes.